# Andrew C Sedillo, MD – FDA Inspection, Sep 3, 2026

Source: https://www.keypedia.com/records/fda_inspections/andrew-c-sedillo-md/55683424-1fab-433c-bffe-18964e40e053
Source feed: FDA_Inspections

> FDA inspection 1334832 of Andrew C Sedillo, MD, September 03, 2026. 1 citation under 21 CFR part 312. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1334832
- Company Name: Andrew C Sedillo, MD
- Inspection Date: 2026-09-03
- Project Area: Bioresearch Monitoring
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Denver District Office
- Citation Count: 1

## Related Documents

- [FDA Inspection 1269750 - 2025-05-07](https://www.keypedia.com/records/fda_inspections/andrew-c-sedillo-md/9c5ac5af-ccfe-4f85-b0a6-652fdea6ab97)
- FDA Inspection 1108035 - 2019-10-11
- FDA Inspection 1044979 - 2018-02-16
- [FDA Inspection 982272 - 2016-06-02](https://www.keypedia.com/records/fda_inspections/andrew-c-sedillo-md/2fcc55c2-f69b-4201-a936-166cabcc80d7)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/gavin-w-pierce/dfc6cdb8-2a63-42f4-8a19-6d394d16ee4d)

Company: https://www.keypedia.com/companies/andrew-c-sedillo-md/4d92fceb-05ed-4140-ab2f-36edf0630a9f

Office: https://www.keypedia.com/offices/denver-district-office/93b79063-390c-4759-af6c-5da7e388face